TITLE

One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density

AUTHOR(S)
Hughes, J. A.; Conry, B. G.; Male, S. M.; Eastell, R.
PUB. DATE
March 1999
SOURCE
Thorax;Mar1999, p223
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877035

 

Related Articles

  • Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Tattersfield, A. E.; Town, G. I.; Johnell, O.; Picado, C.; Aubier, M.; Braillon, P.; Karlström, R. // Thorax;Apr2001, Vol. 56 Issue 4, p272 

    Background--Inhaled corticosteroids are clearly beneficial for patients with asthma of moderate severity, but the risks and benefits of using them in patients with milder asthma are less clear. We have compared the change in bone mineral density over 2 years in adults with mild asthma randomised...

  • Effects of Inhaled Steroids on Bone Mineral Density, Osteocalcin and Growth Velocity in Asthmatic Children. Hamid, Ehab abd Al; Samy, Mohamed M.; Fawzy, Magy M. // Research Journal of Medicine & Medical Sciences;2009, Vol. 4 Issue 2, p320 

    Inhaled corticosteroids have been established as the most effective treatment for childhood asthma. However, concerns persist regarding their potential effects on bone mineral density and growth velocity. Objectives: To assess bone mineral density and growth velocity during 12 months of inhaled...

  • Should Inhaled Corticosteroids be Used in the Long Term Treatment of Chronic Obstructive Pulmonary Disease? Burge, S. // Drugs;Aug2001, Vol. 61 Issue 11, p1535 

    Chronic obstructive pulmonary disease (COPD) is a progressive disease with alveolar destruction (emphysema) and bronchiolar fibrosis (obstructive bronchitis) in variable proportions. Reducing disease progression, as assessed by forced expiratory volume in 1 second (FEV) decline, health-related...

  • Highlights from the literature.  // Archives of Disease in Childhood;Jul2012, Vol. 97 Issue 7, p676 

    The article focuses on research studies related to children's health. A comparison on the effectiveness of daily low dose inhaled budesonide and intermittent high-dose inhaled budesonide for the treatment of recurrent wheezing and asthma among preschool children found no significant differences...

  • Inhaled Steroids And Increased Bone Loss. Napoli, Maryann // HealthFacts;Oct2001, Vol. 26 Issue 10, p5 

    Deals with a study of young women with asthma which documented reduced bone mineral density as an adverse effect of inhaled steroids.

  • Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease. Fahim, Ahmed; Faruqi, Shoaib; Wright, Caroline E.; Kastelik, Jack A.; Morice, Alyn H. // Annals of Thoracic Medicine;Jul-Sep2012, Vol. 7 Issue 3, p140 

    INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a leading cause of respiratory-related morbidity and mortality. Inhaled steroids are frequently used in patients with moderate to severe disease and may lead to adrenal suppression. OBJECTIVES: The aim of this study was to compare the...

  • Salmeterol/Fluticasone Propionate. McKeage, Kate; Keam, Susan J. // Drugs;2009, Vol. 69 Issue 13, p1799 

    Salmeterol/fluticasone propionate (Seretide/Advair Diskus® [dry powder inhaler] or Seretide/Advair® inhalation aerosol [metered-dose inhaler]) is a fixed-dose combination inhalation agent containing a long-acting b2-adrenoceptor agonist (LABA) plus a corticosteroid. In patients with...

  • Safety of Inhaled Budesonide. Christensson, Camilla; Thorén, Anders; Lindberg, Bengt // Drug Safety;2008, Vol. 31 Issue 11, p965 

    Inhaled corticosteroid (ICS) therapy is central to the long-term management of asthma and is extensively used in the management of chronic obstructive pulmonary disease (COPD). While administration via inhalation limits systemic exposure compared with oral or injected corticosteroids and,...

  • Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients. KOLASANI, BHANU PRAKASH; LANKE, VENU MADHAVI; DIYYA, SUDHEER // Journal of Clinical & Diagnostic Research;Sep2013, Vol. 7 Issue 9, p1908 

    Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of inhaled corticosteroids. Fluticasone...

  • Budesonide/Formoterol Maintenance and Reliever Therapy in Asian Patients (Aged ≥16 Years) with Asthma. Vogelmeier, C.; Naya, I.; Ekelund, J. // Clinical Drug Investigation;2012, Vol. 32 Issue 7, p439 

    Background: The combination of an inhaled corticosteroid (ICS), budesonide, and a rapid long-acting β2-agonist (LABA), formoterol, in a single inhaler for use as maintenance and reliever therapy (Symbicort Turbuhaler SMART™) effectively achieves a high level of asthma control and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics